Doctor profile · Federal record
Dr. Michael Reynolds, MD
Dermatology Physician (CMS: Dermatology) · Procedural Dermatology Physician · Gainesville, GA
- NPI 1487604021
- Accepts Medicare
- MIPS 76.6 / 100 · 2023
- 29 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
605 S Enota Dr Ne
Gainesville, GA 305012437
(770) 538-0208
fax (770) 538-0556 - Mailing address
-
605 Enota Dr
Gainesville, GA 305012437
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- September 30, 2013
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Georgia #046224
- Medicaid
- GA #000814767A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487604021. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,243
Distinct HCPCS
10
Medicare allowed
$404,906
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,540 | 640 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,226 | 1,012 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,083 | 818 | $47 | |
11102 |
Biopsy of related skin growth, first growth | 611 | 494 | $85 | |
17110 |
Destruction of skin growth, 1-14 growths | 413 | 364 | $101 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 374 | 316 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 197 | 180 | $118 | |
11103 |
Biopsy of related skin growth, each additional growth | 189 | 129 | $46 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 105 | 105 | $105 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 91 | 78 | $148 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 174. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$1,131
Transactions
46
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 11 | $331.46 | |
| ABBVIE INC. | 10 | $253.16 | |
| LEO Pharma Inc. | 7 | $179.32 | |
| Dermavant Sciences, Inc. | 5 | $105.56 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $87.46 | |
| Incyte Corporation | 3 | $54.14 | |
| UCB, Inc. | 2 | $50.81 | |
| Novartis Pharmaceuticals Corporation | 1 | $34.92 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.78 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $13.61 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,028
Patients
650
Total drug cost
$150,434
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 146 | 94 | $2,770 |
| Hydrocortisone | Generic | 137 | 95 | $1,060 |
| Triamcinolone Acetonide | Generic | 125 | 92 | $1,657 |
| Doxycycline Hyclate | Generic | 124 | 53 | $3,755 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 114 | 81 | $2,414 |
| Mupirocin | Generic | 73 | 58 | $581 |
| Fluocinonide | Generic | 60 | 40 | $2,840 |
| Clobetasol Propionate | Generic | 57 | 33 | $3,327 |
| Metronidazole | Generic | 39 | 27 | $3,971 |
| Fluorouracil | Generic | 35 | 32 | $5,149 |
Frequently asked questions
What is Dr. Michael Reynolds's medical specialty?
Dr. Michael Reynolds practices Dermatology Physician in Gainesville, GA.
Where does Dr. Michael Reynolds practice?
Dr. Michael Reynolds practices at 605 S Enota Dr Ne, Gainesville, GA 305012437. Office phone: 7705380208.
What is Dr. Michael Reynolds's NPI?
Dr. Michael Reynolds's National Provider Identifier (NPI) is 1487604021, issued by NPPES.
Does Dr. Michael Reynolds accept Medicare assignment?
Yes. Dr. Michael Reynolds accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Reynolds commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.